Limes Schlosskliniken AG

As of June 30, 2026, Limes Schlosskliniken AG carries a market capitalization of 162.38M, placing it among publicly traded companies globally. Its enterprise value stands at 164.41M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Limes Schlosskliniken AG's next confirmed earnings release is scheduled for May 17, 2027.

As of June 30, 2026, Limes Schlosskliniken AG has 297,952.00 shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Limes Schlosskliniken AG maintains a current ratio of 2.31, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Limes Schlosskliniken AG's stock has gained approximately 46.65% over the past 52 weeks. The 50-day moving average sits at 545.20, while the 200-day moving average is 510.79.

As of June 30, 2026, Limes Schlosskliniken AG holds 8.24M in cash and equivalents against 8.76M in total debt, resulting in a net debt position of 515,467.00. Total book value stands at 24.37M, with working capital of 10.94M providing operational flexibility.